Related Experiment Video
Updated: Jul 7, 2026

Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants
Published on: November 28, 2025
Cytoplasmic gelsolin in pheochromocytoma-12 cells forms a complex with amyloid beta-protein
Lina Ji1, Abha Chauhan, Ved Chauhan
1New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY 10314, USA.
Abstract:
Gelsolin exists as secretory (plasma) and cytoplasmic forms. We have reported that plasma gelsolin binds to amyloid beta-protein (Abeta), and inhibits its fibrillization. Others reported that peripheral administration or transgene expression of plasma gelsolin reduces amyloid load in transgenic mouse models of Alzheimer's disease. Here, we report that the expression of cytoplasmic gelsolin in pheochromocytoma-12 cells increases after treatment with hydrogen peroxide. When synthetic Abeta was fortified with cell lysate, cytoplasmic gelsolin co-immunoprecipitated with Abeta. The results suggest that cytoplasmic gelsolin forms a complex with Abeta in a manner like plasma form, and it may also regulate Abeta fibrillization. This report indicates that structural differences between plasma and cytoplasmic gelsolin do not play a key role in their complex formation with Abeta.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Insulin Secretory Vesicles
Matrix Proteoglycans and Glycoproteins

